Other studies confirmed an increased amount of oligomeric Tau in the brain of AD patients compared to control, suggesting the possible role of oligomeric Tau as an early biomarker of the disease and the importance of further investigating the biological significance of this particular aggregation state [93]. The gene discussed is MAPT; the disease is Alzheimer disease.